Testoderm and Hair loss - a phase IV clinical study of FDA data

Summary:

Hair loss is reported only by a few people who take Testoderm.

The phase IV clinical study analyzes which people take Testoderm and have Hair loss. It is created by eHealthMe based on reports of 675 people who have side effects while taking Testoderm from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 26, 2022

675 people reported to have side effects when taking Testoderm.
Among them, 5 people (0.74%) have Hair loss.

What is Testoderm?

Testoderm has active ingredients of testosterone. eHealthMe is studying from 688 Testoderm users for its effectiveness, alternative drugs and more.

What is Hair loss?

Hair loss is found to be associated with 3,714 drugs and 3,262 conditions by eHealthMe.

Number of Testoderm and Hair loss reports submitted per year:

Gender of people who have Hair loss when taking Testoderm *:

female: 0.0 %
male: 100 %

Age of people who have Hair loss when taking Testoderm *:

Common drugs people take besides Testoderm *:

Common side effects people have besides Hair loss *:

Weight Decreased: 2 people, 40.00%
Male Pattern Baldness (hair is lost in a well-defined pattern in male): 1 person, 20.00%
Libido Decreased (loss of interest in sex): 1 person, 20.00%
Hypoaesthesia (reduced sense of touch or sensation): 1 person, 20.00%
Drug Ineffective: 1 person, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Testoderm and have Hair loss?

Check whether Hair loss is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Lindsey SF, Tosti A, "Hair loss induced by tumor necrosis factor alpha inhibitors", J Clin Investigat Dermatol, 2015 Jan .

Related studies

How severe was Hair loss and when was it recovered:

Hair loss in Testoderm

Expand to all the drugs that have ingredients of testosterone:

Hair loss and drugs with ingredients of testosterone (353 reports)

Alternative drugs to, pros and cons of Testoderm:

Testoderm (688 reports)

Hair loss treatments and more:

Hair loss (238,472 reports)

COVID vaccines that are related to Hair loss:

Common drugs associated with Hair loss:

All the drugs that are associated with Hair loss:

Hair loss (3,714 drugs)

Common conditions associated with Hair loss:

Rheumatoid arthritis: 18,564 reports
Multiple sclerosis: 13,366 reports
Breast cancer: 11,002 reports
Chemotherapy: 8,910 reports
High blood pressure: 5,484 reports

All the conditions that are associated with Hair loss:

Hair loss (3,262 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on testosterone (the active ingredients of Testoderm) and Testoderm (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.